🔔 Free filing alerts

Get an email whenever EMMES BIOPHARMA UK LIMITED files anything new at Companies House — new accounts, an officer change, a change of name. No account needed.

E

EMMES BIOPHARMA UK LIMITED

Company no. 04498663 · Private Limited Company
Active
View on Companies House

EMMES BIOPHARMA UK LIMITED is an active 24-year-old company. Worth a closer look: confirmation statement overdue at companies house and 1 outstanding charge. On the plus side, accounts filed and up to date.

Risk indicators1 point to check
Confirmation statement overdue at Companies House
1 outstanding charge — secured debt registered
Has traded under 1 previous name
Active on the Companies House register
Accounts filed and up to date
Established — 24+ years on the register

Automated signals from Companies House filings and this company’s own filed accounts — a prompt for a closer look, not a credit score or a verdict. Verivello is not a credit reference agency.

Company details
Established 10+ years1 chargeName changed
StatusActive
Company number04498663
TypePrivate Limited Company
Incorporated30 Jul 2002 · 24 yrs
Registered officeRegus House Fairbourne Drive, Atterbury, Milton Keynes, MK10 9RG
Nature of business72190 - Other research and experimental development on natural sciences and engineering
Next accounts due30 Sep 2026
Confirmation statement due1 Dec 2025
Previous namesORPHAN REACH LIMITED (05/01/2023) | QED CLINICAL SERVICES LIMITED (20/07/2018)

Filed accounts — year to 31 Dec 2024

FigureAmount
Profit for the year £1,285,539
Fixed assets £604,827
Current assets £16,648,048
Cash at bank £1,152,919
Debtors £15,495,129
Creditors £4,393,948
Net current assets £12,254,100
Total assets less current liabilities £12,858,927
Net assets £12,784,684
🔒 Download the original filed accounts (PDF) and every year’s figures side by side — a Premium feature. Premium →

Figures taken directly from the accounts EMMES BIOPHARMA UK LIMITED filed at Companies House for the financial year ending 31 Dec 2024, read from the machine-readable (iXBRL) tags in the filing itself. Smaller companies may file abridged accounts, so not every figure above will be present for every business. Always check the full filing before relying on these numbers.

Directors & officers

BOND, John Matthew
Director · appointed 18 Aug 2023 · American
CHILUKURI, Sastry Venkata
Director · appointed 20 Sep 2023 · American
RONCO, Peter
Director · appointed 20 Sep 2023 · American

Ownership & control (PSC)

Mr Steven Bruce Klinsky
Individual person with significant control · voting rights 75 to 100 percent
Filing status
AccountsUp to date
Last accounts made up to31 Dec 2024
Next accounts due30 Sep 2026
Confirmation statementOverdue
Last statement17 Nov 2024
Next statement due1 Dec 2025
Accounts typeGroup accounts

Filing position at Companies House. A company keeping accounts and its confirmation statement up to date is a basic sign of good order; anything overdue is worth a question.

Unlock with Premium

Everything above is free. Premium adds these — on EMMES BIOPHARMA UK LIMITED and any other UK company.

🏠 Complete property & land list 🔒 Premium

Every UK property this company owns at HM Land Registry — freehold and leasehold titles, tenure and price paid. The page above shows only the first few.

📄 Downloadable PDF due-diligence report 🔒 Premium

The whole picture — overview, directors, ownership, charges, multi-year financials and a risk summary — as a dated, shareable PDF you can attach to a file note.

📊 Original filed accounts & full history 🔒 Premium

Download the original filed accounts (PDF) and see every filed year’s figures side by side — turnover, profit, assets and equity across the full history, not just the latest year.

Unlock the full picture →

Explore related companies

Data from Companies House (official public register), presented by Verivello for information only — not a credit reference or financial advice. Always verify against the official source. Status & registered office checked live from Companies House · 10 Sep 2026, 20:53 UK.